This video from IQVIA Institute Executive Director Murray Aitken offers a look back at highlights of Institute activities in 2024, including reports and other publications, webinars, and symposia.
A Look Back at 7 Indicators of Progress
Summary of an event at the European Commission titled, Pathway to Success in Cancer Treatment: Achieving Radioligand Therapy Capacity and Readiness in Europe.
Learn about spending and usage of medicines in the past year and outlook to the future, globally and across specific therapy areas and countries.
Discover trends in drug approvals and launches, pipeline activity, and data on clinical trial activity.
Examine the state of the U.S. health system, medicine usage, drug pricing, and costs for patients.
Explore research and development in oncology and the progress being made to improve representativeness of race and ethnicity in clinical trial populations.
Video discussion between Michael Kleinrock, IQVIA Institute, and Craig Burton, Association for Accessible Medicines, on key findings in the IQVIA Institute’s report on Drug Shortages in the U.S. 2023.
Achieving Sustainable Levels of Biosimilar Competition in Europe
Interactions between patient organizations and life sciences companies.